TREEWAY

Treeway is a clinical-stage biotechnology company with a mission to develop therapies to cure ALS. Founded in 2012 by two ALS patients, Treeway is committed to developing drugs that first delay disease progression, then halt or control the disease and finally cure ALS. Currently, Treeway's pipeline consists of two drug therapies, TW001 and TW002. Treeway is continuously assessing several research lines to validate drugable targets.

Also known as: Treeway B.V.

Registration numbers: 56658044 (W)

VAT numbers: NL852242086B01

Primary location: Tilburg Netherlands